Home >> Report Store >> Healthcare >> Non-alcoholic Steatohepatitis Biomarkers Market – Global Forecast to 2025 >
Nonalcoholic Steatotic Hepatitis (NASH) Market, By Types (Serums Biomarkers, Hepatic Fibrosis Biomarkers, Oxidative Stress Biomarkers, and Apoptosis Biomarkers), By Application, and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
110+ Pages | Published Date : 28 / 07 / 17 | Report Code: AV126 | Report Format: PDF
REPORT HIGHLIGHT
The Nonalcoholic steatotic hepatitis (NASH) market is estimated to represent a global market of USD 2,298.6 million by 2025 with growth rate of 25.2%.
Market Dynamics
Nonalcoholic steatotic hepatitis (NASH) is the most prevalent form of progressive liver disease condition. The market is categorized into serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others. Serum biomarkers segment held the largest share of the global market, accounted for more than 40% share. Benefits such as its ability to distinguish simple steatosis from NASH offers competitive advantage over other product segments. On contrary, hepatic fibrosis biomarkers is expected to grow with highest growth rate due to rising interest of companies to invest in this product. However, poorly suited regulatory and reimbursement guidelines pose as a threat to the global market.
Application Takeaway
As per the application section, pharmaceutical industry dominated the overall market. Increasing number of pharma companies involved in research activities of NASH drugs coupled with rising number of clinical studies augments the market growth. This market segment is also expected to grow with highest CAGR owing to the rising initiatives pertaining to the development of NASH drugs.
Regional Takeaway
The spectrum of NAFLD & NASH is increasingly recognized both in the developed as well as developing region due to its prevalence in diabetes, insulin resistance syndrome and in obesity. North America has a well-established healthcare industry and the rising prevalence of NAFLD and NASH are expected to show a steady growth of the market during the coming years. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates,nearly 20% of people with NAFLD are affected by NASH.
Additionally, growing obese population coupled with increasing diabetic patients stimulate the uptake of NASH drugs hence drives the market growth. Current trends in developed regions indicated that the prevalence of obesity will cross more than 40% of the population by 2025. Meanwhile, number of patients affected with diabetes is also increasing at constant rate. These would in turn provides healthy platform for the growth of NASH drugs market during the future period.
Key Vendor Takeaway
Companies such as Allergan, Intercept, Prometheus Laboratories Inc., Gilead Sciences, Galmed Pharmaceuticals, Quest Diagnostic Incorporated, Enzo Biochem, Inc. Bio-Rad Laboratories, Inc. and others are considered to be the key players of this market.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The years considered for the study are:
- Historical Year – 2014 & 2015
- Base Year – 2015
- Estimated Year – 2016
- Projected Year – 2025
TARGET AUDIENCE
- Hospitals
- Manufacturers
- Traders, Distributors, And Suppliers
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET,BY TYPES
- Serums biomarkers
- Hepatic fibrosis biomarkers
- Oxidative stress biomarkers
- Apoptosis biomarkers
- Others
MARKET, BY APPLICATION
- Pharma
- Hospitals
- Academic Institutes
- others
MARKET,BY REGION
- North America
- Europe
- Asia Pacific
- Rest of the World
MARKET,BY COUNTRY
- Further Breakdown of The North America Market
- U.S.
- Canada
- Further Breakdown of The Europe Market
- Germany
- France
- Rest of Europe
- Further Breakdown of The APAC Market
- India
- China
- Rest of APAC
- Further Breakdown of The Rest of the World Market
- Middle East and Africa
- Latin America
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET OVERVIEW
- Study Scope
- Base Year
- Assumption and Methodology
- EXECUTIVE SUMMARY
- Key Market Facts
- Geographical Scenario
- Companies in the Market
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) KEY MARKET TRENDS
- Market Drivers
- Impact Analysis of Market Drivers
- Market Restraints
- Impact Analysis of Market Restraints
- Market Opportunities
- Market Future Trends
- Market Drivers
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) INDUSTRY STUDY
- Company Activity Analysis
- Regulatory Framework Analysis
- Value Chain Analysis
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET LANDSCAPE
- Market Share Analysis
- Key Innovators
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET – BY TYPES:
- Overview
- Serums Biomarkers
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Hepatic Fibrosis Biomarkers
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Oxidative Stress Biomarkers
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Apoptosis biomarkers
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Others
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET – BY APPLICATION:
- Overview
- Pharma
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Hospitals
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Academic Institutes
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Others
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET– BY GEOGRAPHY
- Introduction
- North America
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- S.
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Canada
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Europe
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- France
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Germany
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Rest of Europe
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Asia Pacific (APAC)
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- China
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- India
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Rest of APAC
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Rest of the World
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Latin America
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- Middle East and Africa
- Overview
- Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
- KEY VENDOR ANALYSIS
- Allergan
- Company Overview
- SWOT Analysis
- Key Developments
- Intercept
- Company Overview
- SWOT Analysis
- Key Developments
- Prometheus Laboratories Inc.
- Company Overview
- SWOT Analysis
- Key Developments
- Gilead Sciences
- Company Overview
- SWOT Analysis
- Key Developments
- Galmed Pharmaceuticals
- Company Overview
- SWOT Analysis
- Key Developments
- Quest Diagnostic Incorporated
- Company Overview
- SWOT Analysis
- Key Developments
- Enzo Biochem, Inc.
- Company Overview
- SWOT Analysis
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- SWOT Analysis
- Key Developments
- Allergan
- 360 DEGREE ANALYSTVIEW
- APPENDIX
- Research Methodology
- Abbreviations
- Disclaimer
- Contact Us
SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the NONALCOHOLIC STEATOTIC HEPATITIS (NASH) Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the NONALCOHOLIC STEATOTIC HEPATITIS (NASH) Market by its major segments, which include the type, end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT:
- Understanding of the strategies that are being adopted by the key players in this market to stay competitive
- Extensive analysis of the key players dominating the competitive landscape of this market
- In-depth analysis of the key factors are propelling the growth of the global market
- Detailed analysis of the geographic region that will witness the strongest growth
- Granular analysis of the current market scenario and the expected market grow
AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:
- Official Company’s Website, Financial and Annual Reporting
- Government Statistical Data
- Online Publishing Articles
- Industry Player’s Investor Presentations
- Economic News Articles
- National and International Trade Associations
- The Financial, Business and Mainstream Press
- Industry Study Groups and Other Semi-Official Sources
- Many Other Informative Channels Related to the Market Topics
- Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide
In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.
MARKET FORECAST
Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.
MARKET ANALYSIS
Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.
Why AnalystView?
Trusted Partnership
We strive to become one of the trusted partner of our client by offering value added services and concrete research data.
Tailor Made Solutions
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.
Turnaround Time
Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.
Data Accuracy And Reliablity
We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.
Competitive Pricing
We offer most competitive pricing policy across the research industry
Client Testimonials
Why Choose Us
We devise research report with quality data:
Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.
We work with businesses just like yours:
AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.
Copyright © 2018 All rights reserved.
